Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emawayish Tesema
Observed names:
E. Tesema,
Tesema, Emawayish
Institutions:
United States Agency for International Development,
KNCV TB Plus
Observed institutions:
United States Agency for International Development,
All Africa Leprosy Tuberculosis and Rehabilitation Training Centre,
Armauer Hansen Research Institute,
KNCV TB Plus
ORCID:
0000-0002-6775-4208
Observed ORCID:
0000-0002-6775-4208
OpenAlex ID:
A5044624876
Prevalence of antimicrobial resistance and its clinical implications in Ethiopia: a systematic review
2021
·
Derbew Fikadu Berhe
, Getachew Tesfaye Beyene
, et al.
·
Antimicrobial Resistance and Infection Control
·
87
PDF
Prospects for tuberculosis elimination in Ethiopia: feasibility, challenges, and opportunities
2022
·
Tefera Belachew Agizew
, Zewdu Gashu Dememew
, et al.
·
Pan African Medical Journal
·
26
Treatment Outcomes and Predictors of Outcome in Multidrug Resistance Tuberculosis (MDR-TB) Cohort of Patients in Addis Ababa, Ethiopia
2021
·
Netsanet Aragaw
, Mekonnen Teferi
, et al.
·
American Journal of Health Research
·
8
PDF
Drug-resistant tuberculosis care and treatment outcomes over the last 15 years in Ethiopia: Results from a mixed-method review of trends
2024
·
E. Tesema
, M. Biru
, et al.
·
PLoS ONE
·
5
Experiences of introducing new drugs for drug-resistant TB at the ALERT Hospital, Addis Ababa, Ethiopia, 2017–2019
2021
·
E. Tesema
, F. Wares
, et al.
·
Public Health Action
·
5
Hear this! Audiometry testing saves the hearing of a patient with drug-resistant tuberculosis
2019
·
E. Tesema
, F. Wares
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
2
Descriptors of multidrug-resistant TB deaths in Ethiopia
2023
·
E. Tesema
, Z. G. Dememew
, et al.
·
Public Health Action
·
1
Show more works
View as search
Works count:
9
Citation count:
140
H-index:
5
I10-index:
2
Year
Topic
Type